SULINDAC Drug Patent Profile
✉ Email this page to a colleague
When do Sulindac patents expire, and what generic alternatives are available?
Sulindac is a drug marketed by Ani Pharms, Chartwell Rx, Epic Pharma, Epic Pharma Llc, Rising, Sun Pharm Industries, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulindac profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulindac
A generic version of SULINDAC was approved as sulindac by WATSON LABS on April 3rd, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULINDAC?
- What are the global sales for SULINDAC?
- What is Average Wholesale Price for SULINDAC?
Summary for SULINDAC
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 32 |
| Drug Prices: | Drug price information for SULINDAC |
| Drug Sales Revenues: | Drug sales revenues for SULINDAC |
| DailyMed Link: | SULINDAC at DailyMed |
Recent Clinical Trials for SULINDAC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Healx Limited | Phase 2 |
| Duke University | Phase 2 |
| Memorial Sloan Kettering Cancer Center | Phase 2 |
Pharmacology for SULINDAC
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for SULINDAC
Anatomical Therapeutic Chemical (ATC) Classes for SULINDAC
US Patents and Regulatory Information for SULINDAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | SULINDAC | sulindac | TABLET;ORAL | 072973-002 | Feb 28, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | SULINDAC | sulindac | TABLET;ORAL | 073262-002 | Sep 6, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | SULINDAC | sulindac | TABLET;ORAL | 072713-001 | Aug 30, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | SULINDAC | sulindac | TABLET;ORAL | 072051-001 | Apr 17, 1991 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | SULINDAC | sulindac | TABLET;ORAL | 073262-001 | Sep 6, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | SULINDAC | sulindac | TABLET;ORAL | 071795-001 | Apr 3, 1990 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
